L-carnitine and contribution to normal ...
Document type :
Article dans une revue scientifique: Article original
DOI :
PMID :
Permalink :
Title :
L-carnitine and contribution to normal lipid metabolism: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
Author(s) :
Turck, Dominique [Auteur]
Lille Inflammation Research International Center - U 995 [LIRIC]
Bresson, Jean-Louis [Auteur]
Burlingame, Barbara [Auteur]
Dean, Tara [Auteur]
Fairweather-Tait, Susan [Auteur]
Heinonen, Marina [Auteur]
Hirsch-Ernst, Karen-Ildico [Auteur]
Mangelsdorf, Inge [Auteur]
Mcardle, Harry J. [Auteur]
Naska, Androniki [Auteur]
Neuhauser-Berthold, Monika [Auteur]
Nowicka, Grazyna [Auteur]
Pentieva, Kristina [Auteur]
Sanz, Yolanda [Auteur]
Sjodin, Anders [Auteur]
Stern, Martin [Auteur]
Tome, Daniel [Auteur]
Van Loveren, Henk [Auteur]
Vinceti, Marco [Auteur]
Willatts, Peter [Auteur]
Martin, Ambroise [Auteur]
Strain, Sean [Auteur]
Siani, Alfonso [Auteur]

Lille Inflammation Research International Center - U 995 [LIRIC]
Bresson, Jean-Louis [Auteur]
Burlingame, Barbara [Auteur]
Dean, Tara [Auteur]
Fairweather-Tait, Susan [Auteur]
Heinonen, Marina [Auteur]
Hirsch-Ernst, Karen-Ildico [Auteur]
Mangelsdorf, Inge [Auteur]
Mcardle, Harry J. [Auteur]
Naska, Androniki [Auteur]
Neuhauser-Berthold, Monika [Auteur]
Nowicka, Grazyna [Auteur]
Pentieva, Kristina [Auteur]
Sanz, Yolanda [Auteur]
Sjodin, Anders [Auteur]
Stern, Martin [Auteur]
Tome, Daniel [Auteur]
Van Loveren, Henk [Auteur]
Vinceti, Marco [Auteur]
Willatts, Peter [Auteur]
Martin, Ambroise [Auteur]
Strain, Sean [Auteur]
Siani, Alfonso [Auteur]
Journal title :
EFSA Journal
Abbreviated title :
EFSA J.
Volume number :
16
Publication date :
2018-01-01
ISSN :
1831-4732
English keyword(s) :
lipid metabolism
health claim
L-carnitine
health claim
L-carnitine
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
Following an application from Lonza Ltd., submitted for authorisation of a health claim pursuant toArticle 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Germany, the EFSAPanel on Dietetic Products, ...
Show more >Following an application from Lonza Ltd., submitted for authorisation of a health claim pursuant toArticle 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Germany, the EFSAPanel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on thescientific substantiation of a health claim related to L-carnitine and normal lipid metabolism. The foodthat is proposed as the subject of the health claim is L-carnitine. The Panel considers that L-carnitine issufficiently characterised. The claimed effect proposed by the applicant is‘normal lipid metabolism’.The target population proposed by the applicant is the general population. The Panel considers thatcontribution to normal lipid metabolism is a beneficial physiological effect. The applicant proposes thatthe claim submitted with this application is based on the essentiality of a nutrient. The Panel considersthat the evidence provided does not establish that dietary L-carnitine is required to maintain normallipid metabolism in the target population, for which the claim is intended. The Panel concludes that acause and effect relationship has not been established between the consumption of L-carnitine andcontribution to normal lipid metabolism in the target population.Show less >
Show more >Following an application from Lonza Ltd., submitted for authorisation of a health claim pursuant toArticle 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Germany, the EFSAPanel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on thescientific substantiation of a health claim related to L-carnitine and normal lipid metabolism. The foodthat is proposed as the subject of the health claim is L-carnitine. The Panel considers that L-carnitine issufficiently characterised. The claimed effect proposed by the applicant is‘normal lipid metabolism’.The target population proposed by the applicant is the general population. The Panel considers thatcontribution to normal lipid metabolism is a beneficial physiological effect. The applicant proposes thatthe claim submitted with this application is based on the essentiality of a nutrient. The Panel considersthat the evidence provided does not establish that dietary L-carnitine is required to maintain normallipid metabolism in the target population, for which the claim is intended. The Panel concludes that acause and effect relationship has not been established between the consumption of L-carnitine andcontribution to normal lipid metabolism in the target population.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
CHU Lille
Inserm
Université de Lille
Inserm
Université de Lille
Submission date :
2019-10-22T08:09:31Z
2023-12-05T13:00:54Z
2023-12-05T13:06:02Z
2023-12-05T13:00:54Z
2023-12-05T13:06:02Z
Files
- EFSA Journal - 2018 - - L‐carnitine and contribution to normal lipid metabolism evaluation of a health claim pursuant to.pdf
- Non spécifié
- Open access
- Access the document
Except where otherwise noted, this item's license is described as Attribution-NoDerivs 3.0 United States